{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:32:37Z","timestamp":1779237157582,"version":"3.51.4"},"reference-count":107,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2014,11,18]],"date-time":"2014-11-18T00:00:00Z","timestamp":1416268800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1007\/s10620-014-3432-8","type":"journal-article","created":{"date-parts":[[2014,11,21]],"date-time":"2014-11-21T12:23:15Z","timestamp":1416572595000},"page":"1141-1151","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Recent Advances in Cirrhotic Cardiomyopathy"],"prefix":"10.1007","volume":"60","author":[{"given":"Dimitrios S.","family":"Karagiannakis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Papatheodoridis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiannis","family":"Vlachogiannakos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,11,18]]},"reference":[{"key":"3432_CR1","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/hep.1840080532","volume":"5","author":"RW Schrier","year":"1988","unstructured":"Schrier RW, Arroyo V, Bernardi M, Epstein M, Henriksen JH, Rode\u2019s J. Peripheral artery vasodilatation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology. 1988;5:1151\u20131157.","journal-title":"Hepatology"},{"key":"3432_CR2","doi-asserted-by":"crossref","unstructured":"Iwakiri Y, Groszmann RJ. The hyperdynamic circulation of chronic liver diseases: From the patient to the molecule. Hepatology. 2006;43:S121\u2013S131.157.","DOI":"10.1002\/hep.20993"},{"key":"3432_CR3","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.jhep.2007.08.004","volume":"47","author":"F Salermo","year":"2007","unstructured":"Salermo F, Cazzaniga M, Gobbo G. Pharmacological treatment of hepatorenal syndrome: a note of optimism. J Hepatol. 2007;47:729\u2013731.","journal-title":"J Hepatol"},{"key":"3432_CR4","first-page":"139","volume-title":"Ascites and renal dysfunction in liver disease","author":"S Moller","year":"2005","unstructured":"Moller S, Henriksen JH. The systemic circulation in cirrhosis. In: Gines P, Arroyo V, Rodes J, Schrier RW, eds. Ascites and renal dysfunction in liver disease. 2nd ed. Malden: Blackwell; 2005:139\u2013155.","edition":"2"},{"key":"3432_CR5","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/hep.20766","volume":"42","author":"L Ruiz-del-Arbol","year":"2005","unstructured":"Ruiz-del-Arbol L, Monescillo A, Arocena C, et al. Circulatory function and hepatorenal syndrome in cirrhosis. Hepatology. 2005;42:439\u2013447.","journal-title":"Hepatology"},{"key":"3432_CR6","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jhep.2010.02.023","volume":"53","author":"S Moller","year":"2010","unstructured":"Moller S, Henriksen JH. Cirrhotic cardiomyopathy. J Hepatol. 2010;53:179\u2013190.","journal-title":"J Hepatol"},{"key":"3432_CR7","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1055\/s-2008-1040321","volume":"28","author":"SA Alqahtani","year":"2008","unstructured":"Alqahtani SA, Fouad TR, Lee SS. Cirrhotic cardiomyopathy. Semin Liver Dis. 2008;28:59\u201369.","journal-title":"Semin Liver Dis"},{"key":"3432_CR8","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.jhep.2005.10.034","volume":"44","author":"A Zambruni","year":"2006","unstructured":"Zambruni A, Trevisani F, Caraceni P, Bernardi M. Cardiac electrophysiological abnormalities in patients with cirrhosis. J Hepatol. 2006;44:994\u20131002.","journal-title":"J Hepatol"},{"key":"3432_CR9","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/hep.510270106","volume":"27","author":"M Bernardi","year":"1998","unstructured":"Bernardi M, Calandra S, Colantoni A, et al. Q-T interval prolongation in cirrhosis: prevalence, relationship with severity, and etiology of the disease and possible pathogenetic factors. Hepatology. 1998;27:28\u201334.","journal-title":"Hepatology"},{"key":"3432_CR10","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1038\/ajg.2009.321","volume":"104","author":"RN Rabie","year":"2009","unstructured":"Rabie RN, Cazzaniga M, Salermo F, Wong F. The use of E\/A ratio as a predictor of outcome in cirrhotic patients treated with transjugular intrahepatic porto-systemic shunt. Am J Gastroenterol. 2009;104:2458\u20132466.","journal-title":"Am J Gastroenterol"},{"key":"3432_CR11","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/hep.510300613","volume":"30","author":"F Trevisani","year":"1999","unstructured":"Trevisani F, Sica G, Mainqua P, et al. Autonomic dysfunction and hyperdynamic circulation in cirrhosis with ascites. Hepatology. 1999;30:1387\u20131392.","journal-title":"Hepatology"},{"key":"3432_CR12","doi-asserted-by":"crossref","unstructured":"Dumcke CW, Moller S. Autonomic dysfunction in cirrhosis and portal hypertension. Scand J Clin Lab Invest. 2008;68:437\u2013447.","DOI":"10.1080\/00365510701813096"},{"key":"3432_CR13","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/hep.1840120306","volume":"12","author":"SS Lee","year":"1990","unstructured":"Lee SS, Marty J, Mantz J, Samain E, Braillon A, Lebrec D. Desensitization of myocardial beta-adrenergic receptors in cirrhotic rats. Hepatology. 1990;12:481\u2013485.","journal-title":"Hepatology"},{"key":"3432_CR14","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1096\/fasebj.4.11.2165947","volume":"4","author":"WP Hausdorff","year":"1990","unstructured":"Hausdorff WP, Caron MG, Lefkowitz RJ. Turning of the signal: desensitization of \u03b2-adrenergic receptor function. FASEB J. 1990;4:2881\u20132889.","journal-title":"FASEB J"},{"key":"3432_CR15","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1053\/gast.1996.v110.pm8613009","volume":"110","author":"Z Ma","year":"1996","unstructured":"Ma Z, Miyamoto A, Lee SS. Role of altered beta-adrenoceptor signal transduction in the pathogenesis of cirrhotic cardiomyopathy in rats. Gastroenterology. 1996;110:1191\u20131198.","journal-title":"Gastroenterology"},{"key":"3432_CR16","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/S0168-8278(97)80259-0","volume":"26","author":"Z Ma","year":"1997","unstructured":"Ma Z, Lee SS, Meddings JB. Effects of altered cardiac membrane fluidity on beta-adrenergic receptor signalling in rats with cirrhotic cardiomyopathy. J Hepatol. 1997;26:904\u2013912.","journal-title":"J Hepatol"},{"key":"3432_CR17","first-page":"G87","volume":"267","author":"Z Ma","year":"1994","unstructured":"Ma Z, Meddings JB, Lee SS. Membrane physical properties determine cardiac b-adrenergic receptor function in cirrhotic rats. Am J Physiol. 1994;267:G87\u2013G93.","journal-title":"Am J Physiol"},{"key":"3432_CR18","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1042\/cs0910733","volume":"91","author":"MC Ortiz","year":"1996","unstructured":"Ortiz MC, Fortepiani LA, Martinez C, Atucha NM, Garcia-Estan J. Vascular hyporesponsiveness in aortic rings from cirrhotic rats: role of nitric oxide and endothelium. Clin Sci (Lond). 1996;91:733\u2013738.","journal-title":"Clin Sci (Lond)"},{"key":"3432_CR19","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1472-8206.2006.00431.x","volume":"20","author":"F Ebrahimi","year":"2006","unstructured":"Ebrahimi F, Tavacoli S, Hairasouliha AR, et al. Involvement of endogenous opioid peptides and nitric oxide in the blunted chronotropic and inotropic responses to beta-adrenergic stimulation in cirrhotic rats. Fundam Clin Pharmacol. 2006;20:461\u2013471.","journal-title":"Fundam Clin Pharmacol"},{"key":"3432_CR20","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0033-0620(05)80004-0","volume":"38","author":"JM Hare","year":"1995","unstructured":"Hare JM, Colucci WS. Role of nitric oxide in the regulation of myocardial function. Prog Cardiovasc Dis. 1995;38:155\u2013166.","journal-title":"Prog Cardiovasc Dis"},{"key":"3432_CR21","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1161\/01.RES.79.3.363","volume":"79","author":"RA Kelly","year":"1996","unstructured":"Kelly RA, Balligand JL, Smith TW. Nitric oxide and cardiac function. Circ Res. 1996;79:363\u2013380.","journal-title":"Circ Res"},{"key":"3432_CR22","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0016-5085(00)70180-6","volume":"118","author":"H Liu","year":"2000","unstructured":"Liu H, Ma Z, Lee SS. Contribution of nitric oxide to the pathogenesis of cirrhotic cardiomyopathy in bile duct-ligated rats. Gastroenterology. 2000;118:937\u2013944.","journal-title":"Gastroenterology"},{"key":"3432_CR23","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jhep.2010.03.011","volume":"53","author":"YY Yang","year":"2010","unstructured":"Yang YY, Liu H, Nam SW, Kunos G, Lee SS. Mechanisms of TNF\u03b1-induced cardiac dysfunction in cholestatic bile duct-ligated mice: interaction between TNF\u03b1 and endocannabinoids. J Hepatol. 2010;53:298\u2013306.","journal-title":"J Hepatol"},{"key":"3432_CR24","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/sj.bjp.0706331","volume":"146","author":"SE Gaskari","year":"2005","unstructured":"Gaskari SE, Liu H, Moezi L, et al. Role of endocannabinoids in the pathogenesis of cirrhotic cardiomyopathy in bile duct-ligated rats. Br J Pharmacol. 2005;146:315\u2013323.","journal-title":"Br J Pharmacol"},{"key":"3432_CR25","first-page":"H2085","volume":"276","author":"D Gebremedhin","year":"1999","unstructured":"Gebremedhin D, Lange AR, Campbell WB, Hillard CJ, Harder DR. Cannabinoid CB1 receptor of cat cerebral arterial muscle functions to inhibit L-type Ca2+ channel current. Am J Physiol. 1999;276:H2085\u2013H2093.","journal-title":"Am J Physiol"},{"key":"3432_CR26","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/0166-2236(90)90124-S","volume":"13","author":"AC Howlett","year":"1990","unstructured":"Howlett AC, Bidaut-Russell M, Devane WA, et al. The cannabinoid receptor: biochemical, anatomical and behavioral characterization. Trends Neurosci. 1990;13:420\u2013423.","journal-title":"Trends Neurosci"},{"key":"3432_CR27","doi-asserted-by":"crossref","first-page":"H1689","DOI":"10.1152\/ajpheart.00538.2007","volume":"293","author":"S Batkai","year":"2007","unstructured":"Batkai S, Mukhopadhyay P, Harvey-White J, et al. Endocannabinoids acting at CB1 receptors mediate the cardiac contractile dysfunction in vivo in cirrhotic rats. Am J Physiol Heart Circ Physiol. 2007;293:H1689\u2013H1695.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"3432_CR28","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1096\/fasebj.12.11.1035","volume":"12","author":"K Varga","year":"1998","unstructured":"Varga K, Wagner JA, Bridgen DT, Kunos G. Platelet and macrophages derived endogenous cannabinoid are involved in endotoxine induced hypotension. FASEB J. 1998;12:1035\u20131044.","journal-title":"FASEB J"},{"key":"3432_CR29","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1006\/abbi.2001.2500","volume":"393","author":"M Maccarrone","year":"2001","unstructured":"Maccarrone M, De Petrocellis L, Bari M, et al. Lipopolysaccharide downregulates fatty acid amide hydrolase expression and increases anandamide levels in human peripheral lymphocytes. Arch Biochem Biophys. 2001;393:321\u2013328.","journal-title":"Arch Biochem Biophys"},{"key":"3432_CR30","doi-asserted-by":"crossref","first-page":"45034","DOI":"10.1074\/jbc.M306062200","volume":"278","author":"J Liu","year":"2003","unstructured":"Liu J, Batkai S, Pacher P, et al. Lipopolysaccharide induces anandamide synthesis in macrophages via CD14\/MARK\/phosphoinositide 3-kinase\/NK-kappaB independently of platelet-activating factor. J Biol Chem. 2003;278:45034\u201345039.","journal-title":"J Biol Chem"},{"key":"3432_CR31","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2174\/1568010023344878","volume":"1","author":"M Maccarrone","year":"2002","unstructured":"Maccarrone M, Bari M, Battista N, Finazzi-Agro A. Endocannabinoid degradation, endotoxic shock and inflammation. Curr Drug Targets Inflamm Allergy. 2002;1:53\u201363.","journal-title":"Curr Drug Targets Inflamm Allergy"},{"key":"3432_CR32","doi-asserted-by":"crossref","first-page":"R124","DOI":"10.1186\/cc5033","volume":"10","author":"S Rozenberg","year":"2006","unstructured":"Rozenberg S, Besse S, Brisson H, et al. Endotoxin-induced myocardial dysfunction in senescent rats. Crit Care. 2006;10:R124.","journal-title":"Crit Care"},{"key":"3432_CR33","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1007\/s10620-013-2693-y","volume":"58","author":"DS Karagiannakis","year":"2013","unstructured":"Karagiannakis DS, Vlachogiannakos J, Anastasiadis G, Vafiadis-Zouboulis I, Ladas SD. Frequency and severity of cirrhotic cardiomyopathy and its possible relationship with bacterial endotoxaemia. Dig Dis Sci. 2013;58:3029\u20133036.","journal-title":"Dig Dis Sci"},{"key":"3432_CR34","first-page":"G314","volume":"265","author":"G Jacob","year":"1993","unstructured":"Jacob G, Nassar N, Hayam G, et al. Cardiac function and responsiveness to \u03b2-adrenoceptor agonists in rats with obstructive jaundice. Am J Physiol. 1993;265:G314\u2013G320.","journal-title":"Am J Physiol"},{"key":"3432_CR35","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s12012-010-9069-8","volume":"10","author":"JH Zavecz","year":"2010","unstructured":"Zavecz JH, Battarbee HD. The role of lipophilic bile acids in the development of cirrhotic cardiomyopathy. Cardiovasc Toxicil. 2010;10:117\u2013129.","journal-title":"Cardiovasc Toxicil"},{"key":"3432_CR36","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.jhep.2011.02.030","volume":"55","author":"TK Glenn","year":"2011","unstructured":"Glenn TK, Honar H, Liu H, ter Keurs HEDJ, Lee SS. Role of cardiac myofilament proteins titin and collagen in the pathogenesis of diastolic dysfunction in cirrhotic rats. J Hepatol. 2011;55:1249\u20131255.","journal-title":"J Hepatol"},{"key":"3432_CR37","first-page":"G537","volume":"273","author":"CA Ward","year":"1997","unstructured":"Ward CA, Ma Z, Lee SS, Giles WR. Potassium currents in atrial and ventricular myocytes from a rat model of cirrhosis. Am J Physiol. 1997;273:G537\u2013G544.","journal-title":"Am J Physiol"},{"key":"3432_CR38","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1053\/gast.2001.28653","volume":"121","author":"CA Ward","year":"2001","unstructured":"Ward CA, Liu H, Lee SS. Altered cellular calcium regulatory systems in a rat model of cirrhotic cardiomyopathy. Gastroenterology. 2001;121:1209\u20131218.","journal-title":"Gastroenterology"},{"key":"3432_CR39","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1080\/003655201750313289","volume":"36","author":"S Moller","year":"2001","unstructured":"Moller S, Henriksen JH. Cardiovascular dysfunction in cirrhosis. Pathophysiological evidence of a cirrhotic cardiomyopathy. Scand J Gastroenterol. 2001;36:785\u2013794.","journal-title":"Scand J Gastroenterol"},{"key":"3432_CR40","first-page":"179","volume":"51","author":"M Pozzi","year":"2005","unstructured":"Pozzi M, Redaelli E, Ratti L, et al. Time-course of diastolic dysfunction in different stages of chronic HCV related liver diseases. Minerva Gastroenterol Dietol. 2005;51:179\u2013186.","journal-title":"Minerva Gastroenterol Dietol"},{"key":"3432_CR41","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jhep.2004.09.008","volume":"42","author":"M Torregrosa","year":"2005","unstructured":"Torregrosa M, Aguade S, Dos L, et al. Cardiac alterations in cirrhosis: reversibility after liver transplantation. J Hepatol. 2005;42:68\u201374.","journal-title":"J Hepatol"},{"key":"3432_CR42","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3109\/00365529609004879","volume":"31","author":"G Finucci","year":"1996","unstructured":"Finucci G, Desideri A, Sacerdoti D, et al. Left ventricular diastolic function in liver cirrhosis. Scand J Gastroenterol. 1996;31:279\u2013284.","journal-title":"Scand J Gastroenterol"},{"key":"3432_CR43","first-page":"1131","volume":"26","author":"M Pozzi","year":"1997","unstructured":"Pozzi M, Carugo S, Boari G, et al. Evidence of functional and structural cardiac abnormalities in cirrhotic patients with and without ascites. Hepatology. 1997;26:1131\u20131137.","journal-title":"Hepatology"},{"key":"3432_CR44","doi-asserted-by":"crossref","first-page":"475A","DOI":"10.1111\/j.1872-034X.2011.00794.x","volume":"54","author":"F Wong","year":"2011","unstructured":"Wong F, Villamil A, Merli M, et al. Prevalence of diastolic dysfunction in cirrhosis, and its clinical significance. Hepatology.. 2011;54:475A\u2013476A.","journal-title":"Hepatology."},{"key":"3432_CR45","doi-asserted-by":"crossref","first-page":"e396","DOI":"10.1161\/CIRCULATIONAHA.105.579268","volume":"113","author":"CY Ho","year":"2006","unstructured":"Ho CY, Solomon SD. Clinician\u2019s guide to tissue Doppler imaging. Circulation. 2006;113:e396\u2013e398.","journal-title":"Circulation"},{"key":"3432_CR46","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/j.1478-3231.2011.02468.x","volume":"31","author":"K Kazankov","year":"2011","unstructured":"Kazankov K, Holland-Fischer P, Andersen NH, et al. Resting myocardial dysfunction in cirrhosis quantified by tissue Doppler imaging. Liver Int. 2011;31:534\u2013540.","journal-title":"Liver Int"},{"key":"3432_CR47","first-page":"503","volume":"15","author":"UB Andersen","year":"2003","unstructured":"Andersen UB, Moller S, Bendtsen F, Henriksen JH. Cardiac output determined by echocardiography in patients with cirrhosis: comparison with the indicator dilution technique. Eur J Gastroenterol Hepatol. 2003;15:503\u2013507.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"3432_CR48","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.echo.2008.11.023","volume":"22","author":"SF Nagueh","year":"2009","unstructured":"Nagueh SF, Appleton CP, Gillebert TC, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr. 2009;22:107\u2013133.","journal-title":"J Am Soc Echocardiogr"},{"key":"3432_CR49","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1111\/liv.12187","volume":"33","author":"F Sampaio","year":"2013","unstructured":"Sampaio F, Pimenta J, Bettencourt N, et al. Systolic and diastolic dysfunction in cirrhosis: a tissue-Doppler and speckle tracking echocardiography study. Liver int. 2013;33:1158\u20131165.","journal-title":"Liver int"},{"key":"3432_CR50","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1002\/hep.26509","volume":"58","author":"L Ruiz-del Arbol","year":"2013","unstructured":"Ruiz-del Arbol L, Achecar L, Serradilla R, et al. Diastolic dysfunction is a predictor of poor outcomes in patients with cirrhosis, portal hypertension and a normal creatinine. Hepatology. 2013;58:1732\u20131741.","journal-title":"Hepatology"},{"key":"3432_CR51","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1572-0241.2002.05438.x","volume":"97","author":"M Merli","year":"2002","unstructured":"Merli M, Valeriano V, Funaro S, et al. Modifications of cardiac function in cirrhotic patients treated with transjugular intrahepatic portosystemic shunt (TIPS). Am J Gastroenterol. 2002;97:142\u2013148.","journal-title":"Am J Gastroenterol"},{"key":"3432_CR52","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/s00270-009-9696-2","volume":"33","author":"A Kovacs","year":"2010","unstructured":"Kovacs A, Schepke M, Heller J, Schild HH, Flacke S. Short-term effects of transjugular intrahepatic shunt on cardiac function assessed by cardiac MRI: preliminary results. Cardiovasc Intervent Radiol. 2010;33:290\u2013296.","journal-title":"Cardiovasc Intervent Radiol"},{"key":"3432_CR53","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1136\/gut.2006.102467","volume":"56","author":"M Cazzaniga","year":"2007","unstructured":"Cazzaniga M, Salerno F, Pagnozzi G, et al. Diastolic dysfunction is associated with poor survival in cirrhotic patients with transjugular intrahepatic portosystemic shunt. Gut. 2007;56:869\u2013875.","journal-title":"Gut"},{"key":"3432_CR54","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1097\/TP.0b013e318172c936","volume":"85","author":"C Ripoll","year":"2008","unstructured":"Ripoll C, Catalina MV, Yotti R, et al. Cardiac dysfunction during liver transplantation: incidence and preoperative predictors. Transplantation. 2008;85:1766\u20131772.","journal-title":"Transplantation"},{"key":"3432_CR55","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jhep.2012.08.027","volume":"58","author":"A Nazar","year":"2013","unstructured":"Nazar A, Guevara M, Sitges M, et al. Left ventricular function assessed by echocardiography in cirrhosis: relationship to systemic hemodynamics and renal dysfunction. J Hepatol. 2013;58:51\u201357.","journal-title":"J Hepatol"},{"key":"3432_CR56","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1111\/j.1432-2277.2012.01547.x","volume":"25","author":"A Alexopoulou","year":"2012","unstructured":"Alexopoulou A, Papatheodoridis G, Pouriki S, et al. Diastolic myocardial dysfunction does not affect survival in patients with cirrhosis. Transpl Int. 2012;25:1174\u20131181.","journal-title":"Transpl Int"},{"key":"3432_CR57","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ejim.2012.08.007","volume":"24","author":"M Merli","year":"2013","unstructured":"Merli M, Calicchia A, Ruffa A, et al. Cardiac dysfunction in cirrhosis is not associated with the severity of liver disease. Eur J Intern Med. 2013;24:172\u2013176.","journal-title":"Eur J Intern Med"},{"key":"3432_CR58","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ejim.2014.01.011","volume":"25","author":"F Sampaio","year":"2014","unstructured":"Sampaio F, Pimenta J, Bettencourt N, et al. Systolic dysfunction and diastolic dysfunction do not influence medium-term prognosis in patients with cirrhosis. Eur J Intern Med. 2014;25:241\u2013246.","journal-title":"Eur J Intern Med"},{"key":"3432_CR59","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1007\/s12072-014-9544-6","volume":"8","author":"D Karagiannakis","year":"2014","unstructured":"Karagiannakis D, Vlachogiannakos J, Anastasiadis G, Vafiadis-Zoumboulis I, Ladas SD. Diastolic cardiac dysfunction is a predictor of dismal prognosis in patients with liver cirrhosis. Hepatol Int. 2014;8:588\u2013594.","journal-title":"Hepatol Int"},{"key":"3432_CR60","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/0168-8278(95)80286-X","volume":"22","author":"RD Grose","year":"1995","unstructured":"Grose RD, Nolan J, Dilon JF, et al. Exercise-induced left ventricular dysfunction in alcoholic and non-alcoholic cirrhosis. J Hepatol. 1995;22:326\u2013332.","journal-title":"J Hepatol"},{"key":"3432_CR61","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1136\/gut.49.2.268","volume":"49","author":"F Wong","year":"2001","unstructured":"Wong F, Girgrah N, Graba J, Allidina Y, Liu P, Blendis L. The cardiac response to exercise in cirrhosis. Gut. 2001;49:268\u2013275.","journal-title":"Gut"},{"key":"3432_CR62","doi-asserted-by":"crossref","first-page":"376","DOI":"10.3350\/kjhep.2010.16.4.376","volume":"16","author":"MY Kim","year":"2010","unstructured":"Kim MY, Baik SK, Won CS, et al. Dobutamine stress echocardiography for evaluating cirrhotic cardiomyopathy in liver cirrhosis. Korean J Hepatol. 2010;16:376\u2013382.","journal-title":"Korean J Hepatol"},{"key":"3432_CR63","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.mehy.2012.03.032","volume":"79","author":"A Krag","year":"2012","unstructured":"Krag A, Bendtsen F, Burroughs AK, Moller S. The cardiorenal link in advanced cirrhosis. Med Hypotheses. 2012;79:53\u201355.","journal-title":"Med Hypotheses"},{"key":"3432_CR64","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.ijcard.2012.09.089","volume":"167","author":"S Moller","year":"2013","unstructured":"Moller S, Hove JD, Dixen U, Bendtsen F. New insights into cirrhotic cardiomyopathy. Int J Cardiol. 2013;167:1101\u20131108.","journal-title":"Int J Cardiol"},{"key":"3432_CR65","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1136\/gut.2009.180570","volume":"59","author":"A Krag","year":"2010","unstructured":"Krag A, Bendtsen F, Henriksen JH, Moller S. Low cardiac output predicts development of hepatorenal syndrome and survival in patients with cirrhosis and ascites. Gut. 2010;59:105\u2013110.","journal-title":"Gut"},{"key":"3432_CR66","first-page":"1210","volume":"38","author":"L Ruiz-Del-Arbol","year":"2003","unstructured":"Ruiz-Del-Arbol L, Urman J, Fernandez J. et al. Systemic, renal, and hepatic hemodynamic derangement in cirrhotic patients with spontaneous bacterial peritonitis Hepatology. 2003;38:1210\u20131218.","journal-title":"Systemic, renal, and hepatic hemodynamic derangement in cirrhotic patients with spontaneous bacterial peritonitis Hepatology"},{"key":"3432_CR67","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1136\/gut.52.10.1511","volume":"52","author":"JH Henriksen","year":"2003","unstructured":"Henriksen JH, Goetze JP, Fuglsang S, et al. Increased circulating pro-brain natriuretic peptide (proBNP) and brain natriuretic peptide (BNP) in patients with cirrhosis: relation to cardiovascular dysfunction and severity of disease. Gut. 2003;52:1511\u20131517.","journal-title":"Gut"},{"key":"3432_CR68","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/j.1478-3231.2010.02266.x","volume":"30","author":"J Pimenta","year":"2010","unstructured":"Pimenta J, Paulo C, Gomes A, Silva S, Rocha-Goncalves F, Bettencourt P. B-type natriuretic peptide is related to cardiac function and prognosis in hospitalized patients with decompensated cirrhosis. Liver Int. 2010;30:1059\u20131066.","journal-title":"Liver Int"},{"key":"3432_CR69","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1432-2277.2011.01219.x","volume":"24","author":"FH Saner","year":"2011","unstructured":"Saner FH, Neumann T, Canbay A, et al. High brain-natriuretic peptide level predicts cirrhotic cardiomyopathy in liver transplant patients. Transpl Int. 2011;24:425\u2013432.","journal-title":"Transpl Int"},{"key":"3432_CR70","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1586\/egh.11.86","volume":"6","author":"M Bernardi","year":"2012","unstructured":"Bernardi M, Maggioli C, Dibra V, Zaccherini G. QT interval prolongation in liver cirrhosis: innocent bystander or serious threat? Expert Rev Gastroenterol Hepatol. 2012;6:57\u201366.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"3432_CR71","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0168-8278(03)00057-6","volume":"38","author":"F Trevisani","year":"2003","unstructured":"Trevisani F, Merli M, Savelli F, et al. QT interval in patients with non-cirrhotic portal hypertension and in cirrhotic patients treated with transjugular intrahepatic porto-systemic shunt. J Hepatol. 2003;38:461\u2013467.","journal-title":"J Hepatol"},{"key":"3432_CR72","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.jhep.2005.04.015","volume":"43","author":"H Ytting","year":"2005","unstructured":"Ytting H, Henriksen JH, Fuglsang S, Bendtsen F, Moller S. Prolonged Q-Tc interval in mild portal hypertensive cirrhosis. J Hepatol. 2005;43:637\u2013644.","journal-title":"J Hepatol"},{"key":"3432_CR73","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.jhep.2007.03.013","volume":"47","author":"S Hansen","year":"2007","unstructured":"Hansen S, Moller S, Bendtsen F, Jensen G, Henriksen JH. Diurnal variation and dispersion in QT interval in cirrhosis: relation to haemodynamic changes. J Hepatol. 2007;47:373\u2013380.","journal-title":"J Hepatol"},{"key":"3432_CR74","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jhep.2007.11.012","volume":"48","author":"A Zambruni","year":"2008","unstructured":"Zambruni A, Trevisani F, Di Micoli A, et al. Effect of chronic \u03b2-blockage on QT interval in patients with liver cirrhosis. J Hepatol. 2008;48:415\u2013421.","journal-title":"J Hepatol"},{"key":"3432_CR75","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0168-8278(02)00010-7","volume":"36","author":"JH Henriksen","year":"2002","unstructured":"Henriksen JH, Fuglsang S, Bendtsen F, Christensen E, Moller S. Dyssynchronous electrical and mechanical systole in patients with cirrhosis. J Hepatol. 2002;36:513\u2013520.","journal-title":"J Hepatol"},{"key":"3432_CR76","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1053\/j.jvca.2003.09.010","volume":"17","author":"DL Reich","year":"2003","unstructured":"Reich DL, Wood RK Jr, Emre S, et al. Association of intraoperative hypotension and pulmonary hypertension with adverse outcomes after orthotopic liver transplantation. J Cardiothorac Vasc Anesth. 2003;17:699\u2013702.","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"3432_CR77","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1378\/chest.98.5.1210","volume":"98","author":"FL Glauser","year":"1990","unstructured":"Glauser FL. Systemic hemodynamic and cardiac function changes in patients undergoing orthotopic liver transplantation. Chest. 1990;98:1210\u20131215.","journal-title":"Chest"},{"key":"3432_CR78","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/hep.1840170302","volume":"17","author":"M Navasa","year":"1993","unstructured":"Navasa M, Feu F, Garcia-Pagan JC, et al. Hemodynamic and humoral changes after liver transplantation in patients with cirrhosis. Hepatology. 1993;17:355\u2013360.","journal-title":"Hepatology"},{"key":"3432_CR79","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1002\/hep.510230529","volume":"23","author":"R Mohamed","year":"1996","unstructured":"Mohamed R, Forsey PR, Davies MK, Neuberger JM. Effect of liver transplantation on QT interval prolongation and autonomic dysfunction in end-stage liver disease. Hepatology. 1996;23:1128\u20131134.","journal-title":"Hepatology"},{"key":"3432_CR80","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/hep.1840150214","volume":"15","author":"JM Henderson","year":"1992","unstructured":"Henderson JM, Mackay GJ, Hooks M, et al. High cardiac output of advanced liver diseases persists after orthotopic liver transplantation. Hepatology. 1992;15:258\u2013262.","journal-title":"Hepatology"},{"key":"3432_CR81","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/hep.510300112","volume":"30","author":"F Piscaglia","year":"1999","unstructured":"Piscaglia F, Zironi G, Gaiani S, et al. Systemic and splanchnic hemodynamic changes after liver transplantation for cirrhosis: a long-term prospective study. Hepatology. 1999;30:58\u201364.","journal-title":"Hepatology"},{"key":"3432_CR82","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1002\/hep.25915","volume":"56","author":"EA Tsochatzis","year":"2012","unstructured":"Tsochatzis EA, Bosch J, Burroughs AK. New therapeutic paradigm for patients with cirrhosis. Hepatology. 2012;56:1983\u20131992.","journal-title":"Hepatology"},{"key":"3432_CR83","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jhep.2010.03.013","volume":"53","author":"P Tandon","year":"2010","unstructured":"Tandon P, Abraldes JG, Berzigotti A, Garcia-Pagan JC, Bosch J. Renin-angiotensin-aldosterone inhibitors in the reduction of portal pressure: a systematic review and meta-analysis. J Hepatol. 2010;53:273\u2013282.","journal-title":"J Hepatol"},{"key":"3432_CR84","doi-asserted-by":"crossref","first-page":"5229","DOI":"10.1016\/j.ijcard.2013.08.027","volume":"168","author":"KY Wong","year":"2013","unstructured":"Wong KY, Wong SY, McSwiggan S, et al. Myocardial fibrosis and QTc are reduced following treatment with spironolactone or amiloride in stroke survivors: a randomised placebo-controlled cross-over trial. Int J Cardiol. 2013;168:5229\u20135233.","journal-title":"Int J Cardiol"},{"key":"3432_CR85","doi-asserted-by":"crossref","first-page":"e000790","DOI":"10.1161\/JAHA.114.000790","volume":"3","author":"OR Coelho-Filho","year":"2014","unstructured":"Coelho-Filho OR, Shah RV, Neilan TG, et al. Cardiac magnetic resonance assessment of interstitial myocardial fibrosis and cardiomyocyte hypertrophy in hypertensive mice treated with spironolactone. J Am Heart Assoc. 2014;3:e000790.","journal-title":"J Am Heart Assoc"},{"key":"3432_CR86","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1111\/j.1572-0241.2005.41060.x","volume":"100","author":"M Pozzi","year":"2005","unstructured":"Pozzi M, Grassi G, Ratti L, et al. Cardiac, neuroadrenergic and portal hemodynamic effects of prolonged aldosterone blockage in postviral child A cirrhosis. Am J Gastroenterol. 2005;100:1110\u20131116.","journal-title":"Am J Gastroenterol"},{"key":"3432_CR87","first-page":"332","volume":"22","author":"G D\u2019Amico","year":"1995","unstructured":"D\u2019Amico G, Pagliaro L, Bosch J. The treatment of portal hypertension: a meta-analytic review. Hepatology. 1995;22:332\u2013354.","journal-title":"Hepatology"},{"key":"3432_CR88","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S0168-8278(01)00300-2","volume":"36","author":"V Andreu","year":"2002","unstructured":"Andreu V, Perello A, Moitinho E, et al. Total effective vascular compliance in patients with cirrhosis. The role of propranolol. J Hepatol. 2002;36:356\u2013361.","journal-title":"J Hepatol"},{"key":"3432_CR89","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1111\/j.1572-0241.2004.40179.x","volume":"99","author":"HC Lin","year":"2004","unstructured":"Lin HC, Yang YY, Hou MC, Huang YT, Lee FY, Lee SD. Acute administration of carvedilol is more effective than propranolol plus isosorbide-5-mononitrate in the reduction of portal pressure in patients with viral cirrhosis. Am J Gastroenterol. 2004;99:1953\u20131958.","journal-title":"Am J Gastroenterol"},{"key":"3432_CR90","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1053\/jhep.2002.36947","volume":"36","author":"R Banares","year":"2002","unstructured":"Banares R, Moitinho E, Matilla A, et al. Randomised comparison of long-term carvedilol and propranolol administration in the treatment of portal hypertension in cirrhosis. Hepatology. 2002;36:1367\u20131373.","journal-title":"Hepatology"},{"key":"3432_CR91","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.yjmcc.2005.02.023","volume":"38","author":"L Dalla Libera","year":"2005","unstructured":"Dalla Libera L, Ravara B, Gobbo V, et al. Skeletal muscle myofibrillar protein oxidation in heart failure and the protective effect of carvedilol. J Mol Cell Cardiol. 2005;38:803\u2013807.","journal-title":"J Mol Cell Cardiol"},{"key":"3432_CR92","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1536\/ihj.47.607","volume":"47","author":"S Nanjo","year":"2006","unstructured":"Nanjo S, Yamazaki J, Yoshikawa K, Ishii T, Togane Y. Carvedilol prevents myocardial fibrosis in hamsters. Int Heart J. 2006;47:607\u2013616.","journal-title":"Int Heart J"},{"key":"3432_CR93","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1179\/135100005X38879","volume":"10","author":"GE Ronsein","year":"2005","unstructured":"Ronsein GE, Guidi DB, Benassi JC, Filho DW, Pedrosa RC. Cytoprotective effects of carvedilol against oxygen free radical generation in rat liver. Redox Rep. 2005;10:131\u2013137.","journal-title":"Redox Rep"},{"key":"3432_CR94","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.dld.2013.10.013","volume":"46","author":"L Hobolth","year":"2014","unstructured":"Hobolth L, Bendtsen F, Hansen EF, Moller S. Effects of carvedilol and propranolol on circulatory regulation and oxygenation in cirrhosis: a randomised study. Dig Liver Dis. 2014;46:251\u2013256.","journal-title":"Dig Liver Dis"},{"key":"3432_CR95","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/S0735-1097(98)00675-5","volume":"33","author":"DV Exner","year":"1999","unstructured":"Exner DV, Dries DL, Waclawiw MA, Shelton B, Domanski MJ. Beta-adrenergic blocking agent use and mortality in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a post hoc analysis of the Studies of Left Ventricular Dysfunction. J Am Coll Cardiol. 1999;33:916\u2013923.","journal-title":"J Am Coll Cardiol"},{"key":"3432_CR96","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/hep.23775","volume":"52","author":"T Serste","year":"2010","unstructured":"Serste T, Melot C, Francoz C, et al. Deleterious effects of beta-blockers on survival in patients with cirrhosis and refractory ascites. Hepatology. 2010;52:1017\u20131022.","journal-title":"Hepatology"},{"key":"3432_CR97","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.jhep.2011.01.034","volume":"55","author":"T Serste","year":"2011","unstructured":"Serste T, Francoz C, Durand F, et al. Beta-blockers cause paracentesis-induced circulatory dysfunction in patients with cirrhosis and refractory ascites: a cross-over study. J Hepatol. 2011;55:794\u2013799.","journal-title":"J Hepatol"},{"key":"3432_CR98","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1177\/09680519020080020501","volume":"8","author":"G Jurgens","year":"2002","unstructured":"Jurgens G, Muller M, Garidel P, et al. Investigation into the interaction of recombinant human serum albumin with Re-lipopolysaccharide and lipid A. J Endotoxin Res. 2002;8:115\u2013126.","journal-title":"J Endotoxin Res"},{"key":"3432_CR99","doi-asserted-by":"crossref","first-page":"20431","DOI":"10.1016\/S0021-9258(17)32010-0","volume":"269","author":"R Dziarski","year":"1994","unstructured":"Dziarski R. Cell-bound albumin is the 70-kDa peptidoglycan-, lipopolysaccharide-, and lipoteichoic acid-binding protein on lymphocytes and macrophages. J Biol Chem. 1994;269:20431\u201320436.","journal-title":"J Biol Chem"},{"key":"3432_CR100","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.jhep.2014.04.012","volume":"61","author":"V Arroyo","year":"2014","unstructured":"Arroyo V, Garcia-Martinez R, Salvatella X. Human serum albumin, systemic inflammation and cirrhosis. J Hepatol. 2014;61:396\u2013407.","journal-title":"J Hepatol"},{"key":"3432_CR101","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.jhep.2004.05.009","volume":"41","author":"J Fernandez","year":"2004","unstructured":"Fernandez J, Navasa M, Garcia-Pagan JC, et al. Effect of intravenous albumin on systemic and hepatic hemodynamics and vasoactive neurohormonal systems in patients with cirrhosis and spontaneous bacterial peritonitis. J Hepatol. 2004;41:384\u2013390.","journal-title":"J Hepatol"},{"key":"3432_CR102","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/hep.20829","volume":"42","author":"J Fernandez","year":"2005","unstructured":"Fernandez J, Monteagudo J, Bargallo X, et al. A randomised unblinded pilot study comparing albumina vs. hydroxyethyl starch in spontaneous bacterial peritonitis. Hepatology. 2005;42:627\u2013634.","journal-title":"Hepatology"},{"key":"3432_CR103","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/hep.26021","volume":"57","author":"A Bortoluzzi","year":"2013","unstructured":"Bortoluzzi A, Ceolotto G, Gola E, et al. Positive cardiac inotropic effect of albumin infusion in rodents with cirrhosis and ascites: molecular mechanisms. Hepatology. 2013;57:266\u2013276.","journal-title":"Hepatology"},{"key":"3432_CR104","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1161\/01.CIR.0000044914.42696.6A","volume":"107","author":"DM Mancini","year":"2003","unstructured":"Mancini DM, Katz SD, Lang CC, et al. Effect of erythropoietin on exercise capacity in patients with moderate to severe chronic heart failure. Circulation. 2003;107:294\u2013299.","journal-title":"Circulation"},{"key":"3432_CR105","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/S0735-1097(01)01248-7","volume":"37","author":"DS Silverberg","year":"2001","unstructured":"Silverberg DS, Wexler D, Sheps D, et al. The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study. J Am Coll Cardiol. 2001;37:1775\u20131780.","journal-title":"J Am Coll Cardiol"},{"key":"3432_CR106","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.dld.2012.06.020","volume":"44","author":"L Liu","year":"2012","unstructured":"Liu L, Liu H, Nam SW, Lee SS. Protective effects of erythropoietin on cirrhotic cardiomyopathy in rats. Dig Liver Dis. 2012;44:1012\u20131017.","journal-title":"Dig Liver Dis"},{"key":"3432_CR107","doi-asserted-by":"crossref","first-page":"14430","DOI":"10.3748\/wjg.v20.i39.14430","volume":"20","author":"J Yao","year":"2014","unstructured":"Yao J, Zhou CS, Ma X, et al. FXR agonist GW4064 alleviates endotoxin-induced hepatic inflammation by repressing macrophage activation. World J Gastroenterol. 2014;20:14430\u201314441.","journal-title":"World J Gastroenterol"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-014-3432-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-014-3432-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-014-3432-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,23]],"date-time":"2022-04-23T01:35:18Z","timestamp":1650677718000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-014-3432-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,18]]},"references-count":107,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["3432"],"URL":"https:\/\/doi.org\/10.1007\/s10620-014-3432-8","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,18]]}}}